Erratum to:CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases  

作　　者：Bai Xue Ping Wang Wenzhen Yu Jing Feng Jie Li Rulian Zhao Zhenglin Yang Xiyun Yan Hongxia Duan 

机构地区：[1]Sichuan Provincial Key Laboratoryfor Human Disease Gene Study,Sichuan Provincial People'sHospital,Schoolof Medicine,University of Electronic Science and Technology of China,Chengdu 610054,China [2]Key Laboratory of Protein and Peptide Pharmaceutical,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China [3]Department of Ophthalmology,People's Hospital,Peking University,Beijing 100044,China [4]Department of Ophthalmology,Sichuan Provincial People's Hospital,University of Electronic Science and Technology of China,Chengdu 61072,China [5]Research Unit for Blindness Prevention of Chinese Academy of Medical Sciences(2019RU026),Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital,Chengdu 610072,China [6]Nanozyme Medical Center,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China [7]College of Life Sciences,University of Chinese Academy of Sciences,Beijing 100049,China

出　　处：《Science China(Life Sciences)》2024年第2期434-434,共1页中国科学（生命科学英文版）

摘　　要：Erratum to:Sci China Life Sciences,Volume 65,Issue 6:1157-1170(2022),https://doi.org/10.1007/s11427-021-2020-0This paper contains four errors in Figure 4 and Figure 5.In Figure 4C,the image labeled as"1%O_(2)+IgG ctrl"is incorect.This image is another one for 1%O_(2) group.We provide a new image as follows for 1%O_(2)+IgG ctrl group.This new image does not affect the conclusion of this article.

关 键 词：FIGURE IMAGE CD146 

分 类 号：R774.1[医药卫生—眼科] G23[医药卫生—临床医学]